URSAPHARM Arzneimittel et CEBINA annoncent un partenariat pour reconvertir l'antihistaminique azélastine afin de lutter contre la COVID-19A remaining selection on progressing the programme is about for your end of 2026, While this does depend upon how Phase Just one progresses, he continued.In several areas, airspace management protocols were not